BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16953221)

  • 41. The LKB1/AMPK polarity pathway.
    Mirouse V; Billaud M
    FEBS Lett; 2011 Apr; 585(7):981-5. PubMed ID: 21185289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New roles for the LKB1-->AMPK pathway.
    Hardie DG
    Curr Opin Cell Biol; 2005 Apr; 17(2):167-73. PubMed ID: 15780593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
    Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
    Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of LKB1 and AMPK in cellular responses to stress and damage.
    Alexander A; Walker CL
    FEBS Lett; 2011 Apr; 585(7):952-7. PubMed ID: 21396365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The LKB1 tumor suppressor negatively regulates mTOR signaling.
    Shaw RJ; Bardeesy N; Manning BD; Lopez L; Kosmatka M; DePinho RA; Cantley LC
    Cancer Cell; 2004 Jul; 6(1):91-9. PubMed ID: 15261145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.
    Brugarolas J; Kaelin WG
    Cancer Cell; 2004 Jul; 6(1):7-10. PubMed ID: 15261137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas.
    Launonen V; Avizienyte E; Loukola A; Laiho P; Salovaara R; Järvinen H; Mecklin JP; Oku A; Shimane M; Kim HC; Kim JC; Nezu J; Aaltonen LA
    Cancer Res; 2000 Feb; 60(3):546-8. PubMed ID: 10676634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
    Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
    Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
    Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
    Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
    van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
    Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LKB1 and AMPK maintain epithelial cell polarity under energetic stress.
    Mirouse V; Swick LL; Kazgan N; St Johnston D; Brenman JE
    J Cell Biol; 2007 May; 177(3):387-92. PubMed ID: 17470638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation.
    Jaleel M; Villa F; Deak M; Toth R; Prescott AR; Van Aalten DM; Alessi DR
    Biochem J; 2006 Mar; 394(Pt 3):545-55. PubMed ID: 16396636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
    Sun L; Liu X; Fu H; Zhou W; Zhong D
    PLoS One; 2016; 11(12):e0168793. PubMed ID: 28033353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial ischemia differentially regulates LKB1 and an alternate 5'-AMP-activated protein kinase kinase.
    Altarejos JY; Taniguchi M; Clanachan AS; Lopaschuk GD
    J Biol Chem; 2005 Jan; 280(1):183-90. PubMed ID: 15507450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tumor suppressor kinase LKB1: lessons from mouse models.
    Ollila S; Mäkelä TP
    J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
    Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
    Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
    Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
    Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.
    Woods A; Johnstone SR; Dickerson K; Leiper FC; Fryer LG; Neumann D; Schlattner U; Wallimann T; Carlson M; Carling D
    Curr Biol; 2003 Nov; 13(22):2004-8. PubMed ID: 14614828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanosecond pulsed electric fields activate AMP-activated protein kinase: implications for calcium-mediated activation of cellular signaling.
    Morotomi-Yano K; Akiyama H; Yano K
    Biochem Biophys Res Commun; 2012 Nov; 428(3):371-5. PubMed ID: 23103546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.